Based on the results of COX multivariate analysis, we utilized the expression levels of CD276 and tumor diameter to construct a nomogram for predicting postoperative PFI in patients with ccRCC, which holds significant clinical application value. This evidence concerns the gene CD276 and nonpapillary renal cell carcinoma.